Cargando…
First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170396/ https://www.ncbi.nlm.nih.gov/pubmed/29725030 http://dx.doi.org/10.1038/s41375-018-0113-1 |
_version_ | 1783360635962130432 |
---|---|
author | Hojjat-Farsangi, M. Daneshmanesh, A. H. Khan, A. S. Shetye, J. Mozaffari, F. Kharaziha, P. Rathje, L.-S. Kokhaei, P. Hansson, L. Vågberg, J. Byström, S. Olsson, E. Löfberg, C. Norström, C. Schultz, J. Norin, M. Olin, T. Österborg, A. Mellstedt, H. Moshfegh, A. |
author_facet | Hojjat-Farsangi, M. Daneshmanesh, A. H. Khan, A. S. Shetye, J. Mozaffari, F. Kharaziha, P. Rathje, L.-S. Kokhaei, P. Hansson, L. Vågberg, J. Byström, S. Olsson, E. Löfberg, C. Norström, C. Schultz, J. Norin, M. Olin, T. Österborg, A. Mellstedt, H. Moshfegh, A. |
author_sort | Hojjat-Farsangi, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6170396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61703962018-10-09 First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells Hojjat-Farsangi, M. Daneshmanesh, A. H. Khan, A. S. Shetye, J. Mozaffari, F. Kharaziha, P. Rathje, L.-S. Kokhaei, P. Hansson, L. Vågberg, J. Byström, S. Olsson, E. Löfberg, C. Norström, C. Schultz, J. Norin, M. Olin, T. Österborg, A. Mellstedt, H. Moshfegh, A. Leukemia Brief Communication Nature Publishing Group UK 2018-03-27 2018 /pmc/articles/PMC6170396/ /pubmed/29725030 http://dx.doi.org/10.1038/s41375-018-0113-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Brief Communication Hojjat-Farsangi, M. Daneshmanesh, A. H. Khan, A. S. Shetye, J. Mozaffari, F. Kharaziha, P. Rathje, L.-S. Kokhaei, P. Hansson, L. Vågberg, J. Byström, S. Olsson, E. Löfberg, C. Norström, C. Schultz, J. Norin, M. Olin, T. Österborg, A. Mellstedt, H. Moshfegh, A. First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title | First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title_full | First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title_fullStr | First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title_full_unstemmed | First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title_short | First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
title_sort | first-in-class oral small molecule inhibitor of the tyrosine kinase ror1 (kan0439834) induced significant apoptosis of chronic lymphocytic leukemia cells |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170396/ https://www.ncbi.nlm.nih.gov/pubmed/29725030 http://dx.doi.org/10.1038/s41375-018-0113-1 |
work_keys_str_mv | AT hojjatfarsangim firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT daneshmaneshah firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT khanas firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT shetyej firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT mozaffarif firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT kharazihap firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT rathjels firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT kokhaeip firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT hanssonl firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT vagbergj firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT bystroms firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT olssone firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT lofbergc firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT norstromc firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT schultzj firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT norinm firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT olint firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT osterborga firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT mellstedth firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells AT moshfegha firstinclassoralsmallmoleculeinhibitorofthetyrosinekinaseror1kan0439834inducedsignificantapoptosisofchroniclymphocyticleukemiacells |